The Rural Challenge of HIV

New study identifies obstacles for UN strategy of treatment as prevention in sub-Saharan Africa.

(Inside Science) — A new map developed by researchers at UCLA in California calls into question whether a U.N. strategy for eliminating AIDS will succeed in parts of sub-Saharan Africa, where the majority of people living with HIV reside.

The map models where people infected with HIV live among the mountains and high plains of Lesotho, a small, landlocked nation in South Africa about the size of Maryland. And in a new study, the UCLA researchers use the data from this model as a roadmap to design an optimal strategy for eliminating HIV.

Their elimination strategy is based on a concept known as “treatment as prevention,” which is built on evidence that treating people with antiretroviral drugs makes them less likely to transmit the virus to others. Many experts now believe the HIV/AIDS pandemic could be ended within a generation if treatment as prevention and other existing means of stopping the virus were fully implemented.

This conviction is enshrined in the “90-90-90 goal” of the Joint United Nations Programme on HIV/AIDS (UNAIDS), which seeks to diagnose 90 percent of people living with HIV, treat 90 percent of those diagnosed and successfully control the virus in 90 percent of those treated, all by 2020.

However, the new research calls into question whether the 90-90-90 strategy as envisioned by the U.N. will succeed. “It won’t in the very rural countries,” said Sally Blower, a professor at UCLA’s David Geffen School of Medicine, who led the study.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below